A detailed history of Geode Capital Management, LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 735,418 shares of HRMY stock, worth $25 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
735,418
Previous 748,703 1.77%
Holding current value
$25 Million
Previous $22.6 Million 30.06%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$30.0 - $39.95 $398,550 - $530,735
-13,285 Reduced 1.77%
735,418 $29.4 Million
Q2 2024

Aug 09, 2024

SELL
$28.81 - $33.01 $146,181 - $167,492
-5,074 Reduced 0.67%
748,703 $22.6 Million
Q1 2024

May 13, 2024

BUY
$29.93 - $35.06 $445,118 - $521,412
14,872 Added 2.01%
753,777 $25.3 Million
Q4 2023

Feb 13, 2024

BUY
$19.2 - $33.78 $374,956 - $659,689
19,529 Added 2.71%
738,905 $23.9 Million
Q3 2023

Nov 13, 2023

BUY
$31.89 - $39.03 $1.85 Million - $2.27 Million
58,070 Added 8.78%
719,376 $23.6 Million
Q2 2023

Aug 11, 2023

BUY
$30.5 - $37.4 $2.67 Million - $3.28 Million
87,681 Added 15.29%
661,306 $23.3 Million
Q1 2023

May 15, 2023

BUY
$30.8 - $53.92 $720,227 - $1.26 Million
23,384 Added 4.25%
573,625 $18.7 Million
Q4 2022

Feb 13, 2023

BUY
$45.4 - $60.91 $906,047 - $1.22 Million
19,957 Added 3.76%
550,241 $30.3 Million
Q3 2022

Nov 14, 2022

BUY
$42.06 - $55.45 $2.59 Million - $3.41 Million
61,465 Added 13.11%
530,284 $23.5 Million
Q2 2022

Aug 12, 2022

BUY
$33.54 - $52.15 $912,455 - $1.42 Million
27,205 Added 6.16%
468,819 $22.9 Million
Q1 2022

May 13, 2022

BUY
$33.14 - $51.13 $556,288 - $858,268
16,786 Added 3.95%
441,614 $21.5 Million
Q4 2021

Feb 11, 2022

BUY
$34.09 - $43.91 $467,646 - $602,357
13,718 Added 3.34%
424,828 $18.1 Million
Q3 2021

Nov 12, 2021

BUY
$25.68 - $38.61 $4.78 Million - $7.19 Million
186,168 Added 82.76%
411,110 $15.8 Million
Q2 2021

Aug 13, 2021

BUY
$25.96 - $33.44 $3.22 Million - $4.15 Million
124,185 Added 123.25%
224,942 $6.35 Million
Q1 2021

May 12, 2021

BUY
$27.56 - $40.37 $257,878 - $377,742
9,357 Added 10.24%
100,757 $3.33 Million
Q4 2020

Feb 12, 2021

BUY
$31.74 - $51.34 $1.43 Million - $2.31 Million
44,904 Added 96.58%
91,400 $3.3 Million
Q3 2020

Nov 13, 2020

BUY
$30.96 - $44.39 $1.44 Million - $2.06 Million
46,496 New
46,496 $1.58 Million

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.02B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.